Meiji Yasuda Life Insurance CO Eli Lilly & CO Transaction History

Meiji Yasuda Life Insurance CO

$5.39 Billion
Q3 2024

A detailed history of Meiji Yasuda Life Insurance CO transactions in Eli Lilly & CO stock. As of the latest transaction made, Meiji Yasuda Life Insurance CO holds 31,232 shares of LLY stock, worth $23.4 Million. This represents 0.51% of its overall portfolio holdings.

Number of Shares

31,232

Previous 32,299 3.3%

Holding current value

$23.4 Million

Previous $29.2 Million 5.38%

% of portfolio

0.51%

Previous 0.59%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$772.14 - $960.02 $823,873 - $1.02 Million	-1,067 Reduced 3.3%	31,232 $27.7 Million
Q2 2024 Aug 12, 2024	SELL	$724.87 - $909.04 $499,435 - $626,328	-689 Reduced 2.09%	32,299 $29.2 Million
Q1 2024 May 15, 2024	BUY	$592.2 - $792.28 $2.54 Million - $3.4 Million	4,295 Added 14.97%	32,988 $25.7 Million
Q4 2023 Feb 14, 2024	BUY	$525.19 - $619.13 $2.7 Million - $3.18 Million	5,132 Added 21.78%	28,693 $16.7 Million
Q3 2023 Nov 13, 2023	BUY	$434.7 - $599.3 $2.28 Million - $3.15 Million	5,248 Added 28.66%	23,561 $12.7 Million
Q2 2023 Aug 14, 2023	SELL	$350.74 - $468.98 $141,348 - $188,998	-403 Reduced 2.15%	18,313 $8.59 Million
Q1 2023 May 10, 2023	BUY	$310.63 - $364.82 $1.04 Million - $1.23 Million	3,358 Added 21.86%	18,716 $6.43 Million
Q4 2022 Feb 14, 2023	SELL	$321.55 - $374.67 $41,801 - $48,707	-130 Reduced 0.84%	15,358 $5.62 Million
Q3 2022 Nov 14, 2022	BUY	$296.48 - $337.87 $1.19 Million - $1.35 Million	4,000 Added 34.82%	15,488 $5.01 Million
Q2 2022 Aug 16, 2022	BUY	$278.73 - $327.27 $917,300 - $1.08 Million	3,291 Added 40.15%	11,488 $3.73 Million
Q1 2022 May 17, 2022	SELL	$234.69 - $291.66 $199,721 - $248,202	-851 Reduced 9.41%	8,197 $2.35 Million
Q4 2021 Feb 14, 2022	BUY	$224.85 - $279.04 $34,402 - $42,693	153 Added 1.72%	9,048 $2.5 Million
Q3 2021 Nov 12, 2021	SELL	$221.6 - $272.71 $157,779 - $194,169	-712 Reduced 7.41%	8,895 $2.06 Million
Q2 2021 Aug 16, 2021	SELL	$180.55 - $233.54 $194,452 - $251,522	-1,077 Reduced 10.08%	9,607 $2.21 Million
Q1 2021 May 14, 2021	SELL	$164.32 - $212.72 $157,747 - $204,211	-960 Reduced 8.24%	10,684 $2 Million
Q4 2020 Feb 12, 2021	SELL	$130.46 - $172.63 $254,657 - $336,973	-1,952 Reduced 14.36%	11,644 $1.97 Million
Q3 2020 Nov 12, 2020	BUY	$146.22 - $169.13 $63,167 - $73,064	432 Added 3.28%	13,596 $2.01 Million
Q2 2020 Aug 13, 2020	SELL	$136.42 - $164.18 $54,158 - $65,179	-397 Reduced 2.93%	13,164 $2.16 Million
Q1 2020 May 14, 2020	BUY	$119.05 - $147.35 $182,741 - $226,182	1,535 Added 12.76%	13,561 $1.88 Million
Q4 2019 Feb 14, 2020	SELL	$106.92 - $132.43 $38,491 - $47,674	-360 Reduced 2.91%	12,026 $1.58 Million
Q3 2019 Nov 13, 2019	BUY	$106.79 - $116.16 $88,849 - $96,645	832 Added 7.2%	12,386 $1.39 Million
Q2 2019 Aug 14, 2019	SELL	$110.79 - $129.32 $178,704 - $208,593	-1,613 Reduced 12.25%	11,554 $1.28 Million
Q1 2019 May 14, 2019	SELL	$111.31 - $131.02 $197,018 - $231,905	-1,770 Reduced 11.85%	13,167 $1.71 Million
Q4 2018 Feb 12, 2019	SELL	$105.9 - $118.64 $63,540 - $71,184	-600 Reduced 3.86%	14,937 $1.73 Million
Q3 2018 Nov 13, 2018	SELL	$85.86 - $107.31 $65,253 - $81,555	-760 Reduced 4.66%	15,537 $1.67 Million
Q2 2018 Aug 13, 2018	BUY	$75.7 - $86.88 $56,775 - $65,160	750 Added 4.82%	16,297 $1.39 Million
Q1 2018 May 14, 2018	BUY	$74.21 - $87.6 $28,199 - $33,288	380 Added 2.51%	15,547 $1.2 Million
Q4 2017 Feb 13, 2018	SELL	$81.94 - $87.89 $175,351 - $188,084	-2,140 Reduced 12.36%	15,167 $1.28 Million
Q3 2017 Nov 13, 2017	BUY	$77.07 - $85.54 $1.33 Million - $1.48 Million	17,307	17,307 $1.48 Million

Others Institutions Holding LLY

# of Institutions

4,004

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $711B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Meiji Yasuda Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Meiji Yasuda Life Insurance CO with notifications on news.

Account

Meiji Yasuda Life Insurance CO Eli Lilly & CO Transaction History